Hypercholesterolemia

Hypercholesterolemia (literally: high blood cholesterol) is the presence of high levels of cholesterolin the blood. It is not a diseasebut a metabolicderangement that can be secondary to many diseases and can contribute to many forms of disease, most notably cardiovascular disease. It is closely related to the terms "Hyperlipidemia" (elevated levels of lipids) and "Hyperlipoproteinemia" (elevated levels of lipoproteins).

Signs and symptoms

Elevated cholesteroldoes not lead to specific symptoms unless it has been longstanding. Some types of hypercholesterolaemia lead to specific physical findings: xanthoma(thickening of tendonsdue to accumulation of cholesterol), xanthelasma palpabrum (yellowish patches around the eyelids) and arcus senilis(white discoloration of the peripheral cornea).

Longstanding elevated hypercholesterolemia leads to accelerated atherosclerosis; this can express itself in a number of cardiovascular diseases:

• Angina pectoris, leading to PTCAor CABG
• Myocardial infarction
• Transient ischemic attacks(TIAs)
• Cerebrovascular accidents/Strokes
• Peripheral artery disease(PAOD)

Diagnosis

When measuring cholesterol, it is important to measure its subfractions before drawing a conclusion on the cause of the problem. The subfractions are LDL, HDLand VLDL. In the past, LDL and VLDL levels were rarely measured directly due to cost concerns. VLDL levels are reflected in the levels of triglycerides(generally about 45% of triglycerides is composed of VLDL). LDL was usually estimated as a calculated value from the other fractions (total cholesterol minus HDL and VLDL); this method is called the Friedewald calculation; specifically: LDL ~= Total Cholesterol - HDL - (0.2 x Triglycerides).

Less expensive (and less accurate) laboratory methods and the Friedewald calculation have long been utilized because of the complexity, labor and expense of the electrophoreticmethods developed in the 1970s to identify the different lipoproteinparticles which transport cholesterol in the blood. As of 1980, the original methods, developed by research work in the mid-1970s cost about $5K, US 1980 dollars, per blood sample/person.

With time, more advanced laboratory analyses have been developed which do measure LDL and VLDL particle sizes and levels, and at far lower cost. These have partly been developed and become more popular as a result of the increasing clinical trial evidence that intentionally changing cholesterol transport patterns, including to certain abnormal values compared to most adults, often has a dramatic effect on reducing, even partially reversing, the atheroscleroticprocess. With ongoing research and advances in laboratory methods, the prices for more sophisticated analyses have markedly decreased, to less than $100, US 2004, by some labs, and with simultaneous increases in the accuracy of measurement for some of the methods.

Classification

See also hyperlipoproteinemiafor biochemical details

Fredrickson classification

Classically, hypercholesterolemia is categorised by its appearance on lipoproteinelectrophoresisby the Fredrickson classification.

• Type I: high chylomicrons
• Type II:
  • Type IIa: high LDL
  • Type IIb: high LDLand VLDL
• Type III: high chylomicronsand IDL (intermediate density lipoprotein)
• Type IV: high triglycerides
• Type V: very similar to Type I, but with high VLDL
• Non-classified forms are:
  • Hypo-alpha lipoproteinemia
  • Hypo-beta lipoproteinemia

Apart from Type II and Type IV, these disorders are very rare. Some have hereditaryas well as acquired forms. If the hypercholesterolemia is hereditary (familial hypercholesterolemia), there is often a family historyof premature atherosclerosis, as well as familial occurrence of the signs mentioned above.

Secondary causes

There is a number of secondary causes for high cholesterol:

• Diabetes mellitusand syndrome X
• Kidneydisease (nephrotic syndrome)
• Hypothyroidism
• anorexia nervosa

Treatment

The treatment depends on the type of hypercholesterolemia. Types IIa and IIb can be treated with diet, statins, fibrates, nicotinic acid, bile acid sequestrants, LDL apheresisand liver transplantation.

In patients without any other risk factors, moderate hypercholesterolemia is often not treated.

According to Framingham Heart Study, people with an age greater than 50 years have no increased overall mortality with either high or low serum cholesterol levels. There is, however, a correlation between falling cholesterol levels over the first 14 years and mortality over the following 18 years (11% overall and 14% CVD death rate increase per 1 mg/dL per year drop in cholesterol levels).

On the other hand, and though less dramatic than the many cardiovascular procedures, some people, especially with newer and more sophisticated information, are changing their eating and especially food supplement patterns, many of the supplements still being prescription agents. Though generally not aware of the internal changes in their cholesteroltransport patterns, recent trials have demonstrated increasing success with some of these strategies; see the LDL, HDLand IVUSsections.

In other words, clinical trails, starting in the 1970s, have repeatedly and increasingly found that normal cholesterolvalues do not necessarily reflect healthy cholesterolvalues. This has increasingly lead to the newer concept of dyslipidemia, despite normo-cholesterolemia. Though each, by design, examine only a single of multiple relevant issues, some of the better recent randomized human outcome trials include ASCOT-LLA, REVERSAL, PROVE-IT, CARDS, Heart Protection Study, HOPE, PROGRESS, COPERNICUS, and especially a newer research approach utilizing a synthetically produced and IV administered human HDL, the Apo A-I Milano Trial.

Carbohydrates

Evidence is accumulating that eating more carbohydrates- especially simpler, more refined carbohydrates - increases levels of triglyceridesin the blood, lowers HDL, and may shift the LDLparticle distribution pattern, even though not elevated, into unhealthy blood transport, atheroma-stimulating patterns. Thus a low fat diet, which often means a higher carbohydrate intake, may be a very unhealthy change. This is consistent with the low fat diet promotion in the US over the last 15-20 years with simultaneous increases in obesityand Diabetes Mellitusrates. However, as with all observational studies, association does not prove cause and effect connection.

Trans fats

An increasing number of researchers are suggesting that a major dietary risk factor for cardiovascular diseases is trans fatty acids, not saturated fats, as had been suggested by the Framingham Heart Study and the FDA plans revised food labeling to include listing trans fat quantities, by 2007. Meanwhile, amount of trans fat can be calculated from the food label by subtracting the various reported fats from the total fat: trans fat = ( total fats - saturated fats - monounsaturates - polyunsaturates).

Cholesterol questioners

There are those that claim that cholesterol itself is a healthy nutrient and that the whole "lipid hypothesis", which links cholesterol with heart disease and atherosclerosis, is incorrect, despite vast research linking elevated cholesterol levels to poor outcomes. Some information can be found at the Weston A. Prince foundation, The International Network of Cholesterol Skeptics, The Cholesterol Mythsand LDL Cholesterol Does NOT Cause Atherosclerosis or Heart Disease.

Cholesterol and alternative medicine

A survey released in May 2004by the National Center for Complementary and Alternative Medicinefocused on who used complementary and alternative medicine(CAM), what was used, and why it was used in the United States by adults age 18 years and over during 2002. According to this survey, CAM was used to treat cholesterol by 1.1% of U.S. adults who used CAM during 2002 ([1]table 3 on page 9). Consistent with previous studies, this study found that the majority of individuals (i.e., 54.9%) used CAM in conjunction with conventional medicine(page 6).simple:Hypercholesterolemia fr:Hypercholestérolémie it:Ipercolesterolemia pt:Hipercolesterolemia

This article is licensed under the GNU Free Documentation License.
It uses material from the http://en.wikipedia.org/wiki/Hypercholesterolemia Wikipedia article Hypercholesterolemia.